Longitudinal Comparison of in Clinic and at Home Administration of the Cogstate Brief Battery and Demonstrated Practice Effects in the Mayo Clinic Study of Aging.
Neuropsychology
cognitively unimpaired
computerized testing
memory
reaction time
Journal
The journal of prevention of Alzheimer's disease
ISSN: 2426-0266
Titre abrégé: J Prev Alzheimers Dis
Pays: Switzerland
ID NLM: 101638820
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
7
5
2021
Statut:
ppublish
Résumé
The Cogstate Brief Battery (CBB) is a computerized cognitive assessment that can be completed in clinic or at home. Design/Objective: This retrospective study investigated whether practice effects / performance trajectories of the CBB differ by location of administration. Participants included 1439 cognitively unimpaired individuals age 50-75 at baseline participating in the Mayo Clinic Study of Aging (MCSA), a population-based study of cognitive aging. Sixty three percent of participants completed the CBB in clinic only and 37% completed CBB both in clinic and at home. The CBB consists of four subtests: Detection, Identification, One Card Learning, and One Back. Linear mixed effects models were used to evaluate performance trajectories in clinic and at home. Results demonstrated significant practice effects between sessions 1 to 2 for most CBB measures. Practice effects continued over subsequent testing sessions, to a lesser degree. Average practice effects/trajectories were similar for each location (home vs. clinic). One Card Learning and One Back accuracy performances were lower at home than in clinic, and this difference was large in magnitude for One Card Learning accuracy. Participants performed faster at home on Detection reaction time, although this difference was small in magnitude. Results suggest the location where the CBB is completed has an important impact on performance, particularly for One Card Learning accuracy, and there are practice effects across repeated sessions that are similar regardless of where testing is completed.
Sections du résumé
BACKGROUND
The Cogstate Brief Battery (CBB) is a computerized cognitive assessment that can be completed in clinic or at home. Design/Objective: This retrospective study investigated whether practice effects / performance trajectories of the CBB differ by location of administration.
PARTICIPANTS/SETTING
Participants included 1439 cognitively unimpaired individuals age 50-75 at baseline participating in the Mayo Clinic Study of Aging (MCSA), a population-based study of cognitive aging. Sixty three percent of participants completed the CBB in clinic only and 37% completed CBB both in clinic and at home.
MEASUREMENTS
The CBB consists of four subtests: Detection, Identification, One Card Learning, and One Back. Linear mixed effects models were used to evaluate performance trajectories in clinic and at home.
RESULTS
Results demonstrated significant practice effects between sessions 1 to 2 for most CBB measures. Practice effects continued over subsequent testing sessions, to a lesser degree. Average practice effects/trajectories were similar for each location (home vs. clinic). One Card Learning and One Back accuracy performances were lower at home than in clinic, and this difference was large in magnitude for One Card Learning accuracy. Participants performed faster at home on Detection reaction time, although this difference was small in magnitude.
CONCLUSIONS
Results suggest the location where the CBB is completed has an important impact on performance, particularly for One Card Learning accuracy, and there are practice effects across repeated sessions that are similar regardless of where testing is completed.
Identifiants
pubmed: 32010922
doi: 10.14283/jpad.2019.35
pmc: PMC7105353
mid: NIHMS1564481
doi:
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
21-28Subventions
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Références
BMC Psychol. 2013 Dec 23;1(1):30
pubmed: 25566378
J Clin Exp Neuropsychol. 2016 Nov;38(9):1026-37
pubmed: 27266359
Neurology. 2010 Sep 7;75(10):889-97
pubmed: 20820000
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Clin Neuropsychol. 2013;27(8):1247-64
pubmed: 24041121
Alzheimers Dement. 2015 Nov;11(11):1367-76
pubmed: 25858683
Clin Neuropsychol. 2012;26(4):543-70
pubmed: 22540222
Clin Neuropsychol. 2010 Nov;24(8):1267-78
pubmed: 21108148
Alzheimers Dement. 2014 Nov;10(6):743-751.e1
pubmed: 24589436
Alzheimers Dement. 2012;8(2):95-104
pubmed: 22404851
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Alzheimers Dement. 2016 Mar;12(3):281-91
pubmed: 26602629
Arch Clin Neuropsychol. 2007 Feb;22(2):249-57
pubmed: 17443923
Clin Neuropsychol. 2015;29(4):542-58
pubmed: 26165425
Clin Neuropsychol. 2019 Aug;33(6):1102-1126
pubmed: 30417735
Arch Clin Neuropsychol. 2014 Aug;29(5):432-41
pubmed: 24813184
Arch Neurol. 1991 Jul;48(7):725-8
pubmed: 1859300
Alzheimers Dement (Amst). 2018 Jun 21;10:573-582
pubmed: 30406176
Arch Clin Neuropsychol. 2010 May;25(3):244-56
pubmed: 20197293
Alzheimers Dement. 2018 Aug;14(8):1063-1076
pubmed: 29754989